CRVS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CRVS shares is 60, representing 44.47% of the company's common stock.

MYDA ADVISORS LLC, in the last quarter, reduced its stake in CRVS by -100% restricting it's holding to 0 shares of worth nearly -. XTX TOPCO LTD also lessened -100% of the CRVS shares from its portfolio, reducing its holding to 0 shares of worth -. TOWERVIEW LLC also shunned CRVS shares holding by -12.45% last quarter which brought its holding to 382.5 thousand shares worth $680.85K.

As per its latest 13F filing, SUSQUEHANNA INTERNATIONAL GROUP, LLP increased its stake in CRVS by 11.94% in the last quarter. The institutional holder raised its holding to 15 thousand shares having worth more than $26.70K. VANGUARD GROUP INC also added 10.57% more shares of CRVS to its portfolio, raising its holding to 1.49 million shares of worth $2.66M. GEODE CAPITAL MANAGEMENT, LLC also increased its CRVS shares holding by 3.16% which brought its holding to 371.76 thousand shares worth $661.89K.

The insider with the most stakes in CRVS is Novo A/S , 10 percent owner at the company. Additionally, CRVS stock is highly held by Thompson Peter A. and ORBIMED ADVISORS LLC among others.

Company executives, directors, and other insiders own 4.02% percent of Corvus Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CRVS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ECOR1 CAPITAL, LLC, ORBIMED ADVISORS LLC, and THOMPSON PETER A..

There have been 0 transaction(s) during the past 6-months in which Corvus Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 0 Corvus Pharmaceuticals, Inc. shares are held by insiders, which represents about 4.02% of CRVS stock.

CRVS 10 percent owner, Novo A/S holds the largest portfolio of the company's shares. CRVS shares owned by Novo total nearly 3.22 million.

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in CRVS which holds 15 thousand shares worth $26.70K or 0.03% of the total CRVS shares outstanding followed by MYDA ADVISORS LLC with ownership of 0 shares representing 0% of the CRVS ownership. XTX TOPCO LTD is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CRVS is concerned, it is a stock which is optionable.

Number of CRVS shares short is 2.93M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 64.26M shares of CRVS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CRVS has 38.00M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CRVS is 3.82.